Del Prete Dolores, Rice Richard C, Rajadhyaksha Anjali M, D'Adamio Luciano
From the Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York 10461 and.
the Division of Pediatric Neurology, Department of Pediatrics, and.
J Biol Chem. 2016 Aug 12;291(33):17209-27. doi: 10.1074/jbc.M116.733626. Epub 2016 Jun 20.
The amyloid precursor protein (APP), whose mutations cause Alzheimer disease, plays an important in vivo role and facilitates transmitter release. Because the APP cytosolic region (ACR) is essential for these functions, we have characterized its brain interactome. We found that the ACR interacts with proteins that regulate the ubiquitin-proteasome system, predominantly with the E3 ubiquitin-protein ligases Stub1, which binds the NH2 terminus of the ACR, and CRL4(CRBN), which is formed by Cul4a/b, Ddb1, and Crbn, and interacts with the COOH terminus of the ACR via Crbn. APP shares essential functions with APP-like protein-2 (APLP2) but not APP-like protein-1 (APLP1). Noteworthy, APLP2, but not APLP1, interacts with Stub1 and CRL4(CRBN), pointing to a functional pathway shared only by APP and APLP2. In vitro ubiquitination/ubiquitome analysis indicates that these E3 ligases are enzymatically active and ubiquitinate the ACR residues Lys(649/650/651/676/688) Deletion of Crbn reduces ubiquitination of Lys(676) suggesting that Lys(676) is physiologically ubiquitinated by CRL4(CRBN) The ACR facilitated in vitro ubiquitination of presynaptic proteins that regulate exocytosis, suggesting a mechanism by which APP tunes transmitter release. Other dementia-related proteins, namely Tau and apoE, interact with and are ubiquitinated via the ACR in vitro This, and the evidence that CRBN and CUL4B are linked to intellectual disability, prompts us to hypothesize a pathogenic mechanism, in which APP acts as a modulator of E3 ubiquitin-protein ligase(s), shared by distinct neuronal disorders. The well described accumulation of ubiquitinated protein inclusions in neurodegenerative diseases and the link between the ubiquitin-proteasome system and neurodegeneration make this concept plausible.
淀粉样前体蛋白(APP)的突变会导致阿尔茨海默病,它在体内发挥着重要作用并促进神经递质释放。由于APP胞质区域(ACR)对这些功能至关重要,我们对其大脑相互作用组进行了表征。我们发现ACR与调节泛素-蛋白酶体系统的蛋白质相互作用,主要是与E3泛素蛋白连接酶Stub1(其结合ACR的NH2末端)和CRL4(CRBN)(由Cul4a/b、Ddb1和Crbn组成,并通过Crbn与ACR的COOH末端相互作用)。APP与类APP蛋白-2(APLP2)具有共同的基本功能,但与类APP蛋白-1(APLP1)没有。值得注意的是,APLP2而非APLP1与Stub1和CRL4(CRBN)相互作用,这表明存在一条仅由APP和APLP2共享的功能途径。体外泛素化/泛素组分析表明,这些E3连接酶具有酶活性并使ACR残基Lys(649/650/651/676/688)泛素化。Crbn的缺失减少了Lys(676)的泛素化,表明Lys(676)在生理上被CRL4(CRBN)泛素化。ACR促进了调节胞吐作用的突触前蛋白的体外泛素化,这提示了APP调节神经递质释放的一种机制。其他与痴呆相关的蛋白质,即Tau和载脂蛋白E,在体外与ACR相互作用并通过ACR被泛素化。这一点,以及CRBN和CUL4B与智力残疾有关的证据,促使我们提出一种致病机制,即APP作为E3泛素蛋白连接酶的调节剂,在不同的神经元疾病中是共享的。神经退行性疾病中泛素化蛋白包涵体的大量积累以及泛素-蛋白酶体系统与神经退行性变之间的联系使得这一概念具有合理性。